Abstract
Objective: Our objective was to evaluate the disease spectrum of thyroid cytopathology and correlation of the Bethesda reporting system with final histopathology in our medical centre. Methods: This retrospective study was conducted from histopathology reports from Galilee Medical Center between August 2013 and September 2017. Results: A total of 287 thyroid fine needle aspirations were included in the study. The majority (55.1%) of these were benign (B2). Surgery was performed on 53 cases and the total malignancy rate was 39.6%. Our study had a favourable accuracy rate of 70%. A B4 Bethesda category had a higher malignancy rate (50%) than previously reported. Conclusion: We found a higher malignancy rate (50%) based on the Bethesda B4 category of the fine needle aspirations in our series, yet it is based on a small sample. The differences in malignancy rates between centres have an important impact on clinical decisions.
Original language | English |
---|---|
Pages (from-to) | 468-474 |
Number of pages | 7 |
Journal | Cytopathology |
Volume | 30 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2019 |
Bibliographical note
Publisher Copyright:© 2019 John Wiley & Sons Ltd
Keywords
- Bethesda classification
- fine needle aspiration
- gene expression classifier
- thyroid cancer
- thyroid nodule